|
|
Article: Following Claritin's Lead, Second-Generation Antihistamines Switching to Over-the-Counter Status Drive the Allergic Rhinitis Prescription Drug Market into a Downward Spiral.
- Article from:
- PR Newswire
- Article date:
- June 20, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Switches from Prescription to OTC Will Have Less of a Dramatic Impact in Europe, According to a New Study from Decision Resources
WALTHAM, Mass., June 20 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, finds that the anticipated switch of second-generation antihistamines from prescription to over-the-counter (OTC) status in each of the seven major markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) will lead to increases in the number of patients opting to self medicate with nonprescription therapies rather than present to a physician ...